Efficacy and safe of Etanercpt (Enbrel) after 12 weeks treatment in patients with ankylosing spondylitis. Objective. To determine the Etanercpt (Enbrel) efficacy in patients with ankylosing spondylitis after 12 weeks treatead. Patients and methods. The clinical and labotories of 5 ankylosing spondylitis patients who were diagnosed and treated by Etanercpt (Enbrel) in Rheumatology department, Bach mai hospital from July, 2011 to November, 2011 were analysed. Results. There are have improvement of both clinical and disease activity such as VAS (from 8.7 to 2.0), BASDAI index (from 12.6 to 3.4), BASFI index (from 7.8 to 1.9) others inplammation indeck: ESR(from 65.5 to 14.5 mm), CRP (from 6.1 to 1.5). No side effect of drug was recognized. Conclusion. Etanercpt (Enbrel) efficalcy in patients with ankylosing spondylitis treatment.
- Đăng nhập để gửi ý kiến